SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (460)3/8/1999 6:07:00 PM
From: WWS  Read Replies (1) of 613
 
One that I've followed, but never purchased, just flamed out on its IND application with a 7-4 vote against approval by its FDA advisory committee. Product was a topical antibiotic salve being tested for diabetic foot ulcers. Salve was derived from magainins, a peptide classification first found in frog skin. Company is Magainin (MAGN) and now trades about 1 1/2. They still have squalamine (from sharks) in the wings pre clinical for possible anti-cancer tx. But company may not be able to raise sufficient funds on their own to take another product through p-III.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News